Omega Healthcare Investors (OHI) Earning Somewhat Critical News Coverage, Accern Reports
Media headlines about Omega Healthcare Investors (NYSE:OHI) have trended somewhat negative on Wednesday, according to Accern. The research group identifies negative and positive news coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Omega Healthcare Investors earned a news sentiment score of -0.01 on Accern’s scale. Accern also gave headlines about the real estate investment trust an impact score of 41.4827281866811 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
These are some of the news headlines that may have impacted Accern Sentiment Analysis’s scoring:
- Top Buys by Directors: Korman’s $2.8M Bet on OHI (nasdaq.com)
- OHI SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of … (globenewswire.com)
- OHI SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Omega Healthcare Investors, Inc. and a Lead Plaintiff Deadline of January 16, 2018 (feeds.benzinga.com)
- Robbins Arroyo LLP: Omega Healthcare Investors, Inc. (OHI) Misled Shareholders According to a Recently Filed Class Action (markets.financialcontent.com)
- Volatile Stock in Focus – Omega Healthcare Investors, Inc., (NYSE: OHI) – Stock Watch (stocksnewstimes.com)
Omega Healthcare Investors (NYSE OHI) traded up $0.14 during trading on Wednesday, hitting $26.92. The stock had a trading volume of 2,312,477 shares, compared to its average volume of 2,175,534. Omega Healthcare Investors has a one year low of $26.43 and a one year high of $35.14. The company has a debt-to-equity ratio of 1.18, a current ratio of 3.40 and a quick ratio of 3.40. The firm has a market capitalization of $5,304.40, a P/E ratio of 7.88, a P/E/G ratio of 2.78 and a beta of 0.49.
The company also recently announced a quarterly dividend, which was paid on Wednesday, November 15th. Shareholders of record on Tuesday, October 31st were given a dividend of $0.65 per share. This represents a $2.60 dividend on an annualized basis and a yield of 9.66%. The ex-dividend date was Monday, October 30th. This is an increase from Omega Healthcare Investors’s previous quarterly dividend of $0.64. Omega Healthcare Investors’s dividend payout ratio is currently 317.08%.
Several research analysts have recently issued reports on OHI shares. ValuEngine downgraded Omega Healthcare Investors from a “buy” rating to a “hold” rating in a research note on Wednesday, September 6th. Zacks Investment Research downgraded Omega Healthcare Investors from a “hold” rating to a “sell” rating in a research note on Thursday, September 28th. Jefferies Group reaffirmed a “hold” rating and issued a $30.00 price objective on shares of Omega Healthcare Investors in a research note on Tuesday, October 3rd. Vetr downgraded Omega Healthcare Investors from a “buy” rating to a “hold” rating and set a $33.33 price objective for the company. in a research note on Thursday, October 19th. Finally, Capital One Financial started coverage on Omega Healthcare Investors in a research note on Monday, October 23rd. They issued an “equal weight” rating and a $34.00 price objective for the company. One research analyst has rated the stock with a sell rating, six have issued a hold rating and two have given a buy rating to the stock. The stock has an average rating of “Hold” and an average price target of $31.83.
In other news, Director Craig R. Callen bought 10,000 shares of the firm’s stock in a transaction on Thursday, November 2nd. The stock was acquired at an average price of $27.38 per share, with a total value of $273,800.00. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Bernard J. Korman bought 100,000 shares of the firm’s stock in a transaction on Tuesday, October 31st. The shares were purchased at an average cost of $28.24 per share, with a total value of $2,824,000.00. Following the transaction, the director now directly owns 903,895 shares in the company, valued at approximately $25,525,994.80. The disclosure for this purchase can be found here. Corporate insiders own 1.54% of the company’s stock.
About Omega Healthcare Investors
Omega Healthcare Investors, Inc is a self-administered real estate investment trust (REIT). The Company maintains a portfolio of long-term healthcare facilities and mortgages on healthcare facilities located in the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.
Receive News & Ratings for Omega Healthcare Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.